Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Mohr

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Medical Genetics|December 28, 2005
Oculo-auriculo-vertebral spectrum (OAVS): clinical evaluation and severity scoring of 53 patients and proposal for a new classificationChristiane Tasse, Stefan Böhringer, Sven Fischer, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Ryan P Wurz, Shimin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitorsTae-Seong Kim, Andrew B Hague, Tony I Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2006
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)Michael A McDonough, Vivian Li, Emily Flashman, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitorsRyan P Wurz, Christine Sastri, Derin C D'Amico, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinaseVictor J Cee, Alan C Cheng, Karina Romero, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Journal of Hepatology|July 12, 2016
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patientMarkus W Löffler, P Anoop Chandran, Karoline Laske, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as Covalent Inhibitors of KRAS<sup>G12C</sup>Youngsook Shin, Joon Won Jeong, Ryan P Wurz, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Medical Genetics|December 28, 2005
Oculo-auriculo-vertebral spectrum (OAVS): clinical evaluation and severity scoring of 53 patients and proposal for a new classificationChristiane Tasse, Stefan Böhringer, Sven Fischer, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Ryan P Wurz, Shimin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitorsTae-Seong Kim, Andrew B Hague, Tony I Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2006
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)Michael A McDonough, Vivian Li, Emily Flashman, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitorsRyan P Wurz, Christine Sastri, Derin C D'Amico, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinaseVictor J Cee, Alan C Cheng, Karina Romero, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Journal of Hepatology|July 12, 2016
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patientMarkus W Löffler, P Anoop Chandran, Karoline Laske, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as Covalent Inhibitors of KRAS<sup>G12C</sup>Youngsook Shin, Joon Won Jeong, Ryan P Wurz, et al.
Pageof 6